title: Optimal management of oropharyngeal and esophageal candidiasis in patients living with HIV infection.
abstract: Mucocutaneous candidiasis is frequently one of the first signs of human immunodeficiency virus (HIV) infection. Over 90% of patients with AIDS will develop oropharyngeal candidiasis (OPC) at some time during their illness. Although numerous antifungal agents are available, azoles, both topical (clotrimazole) and systemic (fluconazole, itraconazole, voriconazole, posaconazole) have replaced older topical antifungals (gentian violet and nystatin) in the management of oropharyngeal candidiasis in these patients. The systemic azoles, are generally safe and effective agents in HIV-infected patients with oropharyngeal candidiasis. A constant concern in these patients is relapse, which is dependent on the degree of immunosuppression commonly seen after topical therapy, rather than with systemic azole therapy. Candida esophagitis (CE) is also an important concern since it occurs in more than 10% of patients with AIDS and can lead to a decrease in oral intake and associated weight loss. Fluconazole has become the most widely used antifungal in the management of mucosal candidiasis. However, itraconazole and posaconazole have similar clinical response rates as fluconazole and are also effective alternative agents. In patients with fluconazole-refractory mucosal candidiasis, treatment options now include itraconazole solution, voriconazole, posaconazole, and the newer echinocandins (caspofungin, micafungin, and anidulafungin).
authors.affiliation: Division of Infectious Diseases, Henry Ford Hospital, Wayne State University School of Medicine, Detroit, MI, USA.
authors.forename: Jose A
authors.initials: JA
authors.lastname: Vazquez
references.citation: Arch Intern Med. 1991 Dec;151(12):2458-64
references.pmid: 1747004
references.citation: Clin Infect Dis. 2006 Apr 15;42(8):1179-86
references.pmid: 16575739
references.citation: J Acquir Immune Defic Syndr (1988). 1993 Dec;6(12):1311-6
references.pmid: 8254467
references.citation: Clin Microbiol Rev. 2004 Oct;17(4):729-59, table of contents
references.pmid: 15489345
references.citation: AIDS. 1991 Nov;5(11):1367-71
references.pmid: 1662959
references.citation: Eur J Clin Microbiol Infect Dis. 1998 Nov;17(11):781-3
references.pmid: 9923519
references.citation: N Engl J Med. 1994 Jan 27;330(4):263-72
references.pmid: 8272088
references.citation: Gut. 1982 Feb;23(2):137-9
references.pmid: 7068036
references.citation: J Chemother. 1992 Dec;4(6):381-6
references.pmid: 1287140
references.citation: Clin Microbiol Rev. 1999 Jan;12(1):40-79
references.pmid: 9880474
references.citation: Eur J Clin Microbiol Infect Dis. 1996 Jun;15(6):446-52
references.pmid: 8839637
references.citation: J Oral Pathol Med. 1991 Aug;20(7):332-6
references.pmid: 1680189
references.citation: Rev Infect Dis. 1990 Mar-Apr;12 Suppl 3:S334-7
references.pmid: 2184511
references.citation: N Engl J Med. 1988 Jun 2;318(22):1439-48
references.pmid: 3285211
references.citation: Eur J Epidemiol. 1995 Apr;11(2):243-4
references.pmid: 7672085
references.citation: Antimicrob Agents Chemother. 1990 Nov;34(11):2267-8
references.pmid: 2073120
references.citation: J Infect Dis. 1985 Dec;152(6):1356-7
references.pmid: 2933473
references.citation: Antimicrob Agents Chemother. 1993 Nov;37(11):2449-53
references.pmid: 8285632
references.citation: Clin Infect Dis. 1998 Feb;26(2):259-72; quiz 273-4
references.pmid: 9502438
references.citation: Eur J Pharm Sci. 2004 Apr;21(5):645-53
references.pmid: 15066665
references.citation: Clin Infect Dis. 1995 Aug;21 Suppl 1:S99-102
references.pmid: 8547520
references.citation: Ann Intern Med. 1992 Oct 15;117(8):655-60
references.pmid: 1308663
references.citation: Future Microbiol. 2007 Jun;2(3):245-56
references.pmid: 17661697
references.citation: Pharmacotherapy. 2007 Mar;27(3):369-88
references.pmid: 17316149
references.citation: Antimicrob Agents Chemother. 2004 Feb;48(2):568-74
references.pmid: 14742211
references.citation: Rev Infect Dis. 1990 Mar-Apr;12 Suppl 3:S364-8
references.pmid: 2184513
references.citation: J Clin Microbiol. 1996 Sep;34(9):2246-54
references.pmid: 8862593
references.citation: Sabouraudia. 1961 Jan;1:8-15
references.pmid: 13764908
references.citation: South Med J. 1967 Nov;60(11):1244-7
references.pmid: 4862923
references.citation: Clin Infect Dis. 1997 Jun;24(6):1204-7
references.pmid: 9195083
references.citation: Chemotherapy. 1996 Sep-Oct;42(5):374-83
references.pmid: 8874977
references.citation: Antimicrob Agents Chemother. 1997 Mar;41(3):575-7
references.pmid: 9055995
references.citation: Ann Intern Med. 1986 Jul;105(1):145
references.pmid: 3717801
references.citation: Scand J Infect Dis. 1995;27(6):613-7
references.pmid: 8685642
references.citation: MMWR Recomm Rep. 2009 Apr 10;58(RR-4):1-207; quiz CE1-4
references.pmid: 19357635
references.citation: Clin Infect Dis. 1996 Oct;23(4):685-93
references.pmid: 8909827
references.citation: Am J Med. 1998 Jan;104(1):33-9
references.pmid: 9528717
references.citation: Cancer. 2008 Jan 1;112(1):204-11
references.pmid: 18044772
references.citation: Ann Intern Med. 1997 May 1;126(9):689-96
references.pmid: 9139554
references.citation: Aliment Pharmacol Ther. 1995 Oct;9(5):553-6
references.pmid: 8580277
references.citation: Am J Med. 2002 Sep;113(4):294-9
references.pmid: 12361815
references.citation: AIDS. 1997 Feb;11(2):163-8
references.pmid: 9030362
references.citation: AIDS. 1994 Jul;8(7):945-50
references.pmid: 7946104
references.citation: Chemotherapy. 1996 Jul-Aug;42(4):308-14
references.pmid: 8804799
references.citation: N Engl J Med. 1995 Mar 16;332(11):700-5
references.pmid: 7854376
references.citation: HIV Clin Trials. 2007 Mar-Apr;8(2):86-97
references.pmid: 17507324
references.citation: Br J Clin Pharmacol. 2004 Feb;57(2):218-22
references.pmid: 14748822
references.citation: Ther Clin Risk Manag. 2007 Aug;3(4):533-42
references.pmid: 18472974
references.citation: AIDS. 1992 Jan;6(1):81-4
references.pmid: 1543569
references.citation: Eur J Clin Microbiol Infect Dis. 1996 Jan;15(1):30-7
references.pmid: 8641300
references.citation: Eur J Clin Pharmacol. 1994;46(2):147-50
references.pmid: 8039534
references.citation: Lancet. 1989 Apr 8;1(8641):746-8
references.pmid: 2564563
references.citation: Infect Immun. 1990 Jan;58(1):260-2
references.pmid: 2152888
references.citation: Clin Infect Dis. 2004 Sep 15;39(6):770-5
references.pmid: 15472806
references.citation: Antimicrob Agents Chemother. 2002 Feb;46(2):451-7
references.pmid: 11796357
references.citation: Pharmacotherapy. 1996 May-Jun;16(3):424-8
references.pmid: 8726601
references.citation: Eur J Clin Microbiol Infect Dis. 1991 Jun;10(6):503-5
references.pmid: 1915385
references.citation: J Infect Dis. 1996 Jan;173(1):219-25
references.pmid: 8537662
references.citation: Am J Med. 1984 Oct 30;77(4D):44-8
references.pmid: 6093531
references.citation: Am J Med. 1984 Jan;76(1):91-4
references.pmid: 6362409
references.citation: Curr Top Med Mycol. 1985;1:1-23
references.pmid: 3916762
references.citation: Clin Infect Dis. 2007 Feb 15;44(4):607-14
references.pmid: 17243069
references.citation: N Engl J Med. 1996 Jun 20;334(25):1674-5
references.pmid: 8628377
references.citation: Int J Clin Pract. 2004 Jun;58(6):612-24
references.pmid: 15311563
references.citation: Clin Pharm. 1991 Mar;10(3):179-94
references.pmid: 2040125
references.citation: AIDS. 1996 Oct;10(12):1369-76
references.pmid: 8902066
references.citation: J Infect Dis. 1983 Jun;147(6):1060-3
references.pmid: 6304203
references.citation: Endoscopy. 1995 Jun;27(5):377-83
references.pmid: 7588352
references.citation: J Antimicrob Chemother. 2004 Jan;53(1):74-80
references.pmid: 14657086
references.citation: Acta Pathol Microbiol Scand. 1962;54:462-72
references.pmid: 13916820
references.citation: AIDS. 1995 May;9(5):533-4
references.pmid: 7639986
references.citation: Antimicrob Agents Chemother. 1998 Jul;42(7):1862-5
references.pmid: 9661037
references.citation: Cochrane Database Syst Rev. 2006 Jul 19;(3):CD003940
references.pmid: 16856025
references.citation: Aliment Pharmacol Ther. 2005 Apr 1;21(7):899-907
references.pmid: 15801925
references.citation: Clin Infect Dis. 1992 Jan;14(1):165-74
references.pmid: 1315160
references.citation: Am J Med. 1981 Nov;71(5):891-5
references.pmid: 7304661
references.citation: Mycoses. 1996;39 Suppl 1:102-6
references.pmid: 8767280
references.citation: Gastroenterology. 1996 Nov;111(5):1169-77
references.pmid: 8898629
references.citation: Scand J Infect Dis. 1995;27(4):391-5
references.pmid: 8658076
references.citation: J Infect Dis. 1997 Jul;176(1):227-32
references.pmid: 9207371
references.citation: Clin Infect Dis. 2005 Nov 15;41(10):1473-80
references.pmid: 16231260
references.citation: Eur J Clin Microbiol Infect Dis. 1996 Mar;15(3):238-42
references.pmid: 8740860
references.citation: AIDS. 1991 May;5(5):519-25
references.pmid: 1863403
references.citation: Eur J Epidemiol. 1993 Jul;9(4):455-6
references.pmid: 8243605
references.citation: Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1996 Oct;82(4):402-7
references.pmid: 8899777
references.citation: Clin Infect Dis. 2001 Nov 1;33(9):1447-54
references.pmid: 11577374
references.citation: Expert Rev Mol Med. 2008 Oct 13;10:e29
references.pmid: 18847522
references.citation: AIDS. 1987 Sep;1(3):175-82
references.pmid: 2831912
references.citation: Gastroenterology. 1976 Nov;71(5):715-9
references.pmid: 964563
references.citation: Clin Infect Dis. 1998 Apr;26(4):960-3
references.pmid: 9564483
references.citation: Br J Clin Pharmacol. 2004 Oct;58(4):345-51
references.pmid: 15373926
references.citation: Ann Intern Med. 1997 Feb 15;126(4):332-3
references.pmid: 9036812
references.citation: J Infect Dis. 1995 Jun;171(6):1448-54
references.pmid: 7539473
references.citation: Clin Infect Dis. 1997 Jan;24(1):28-34
references.pmid: 8994752